545 related articles for article (PubMed ID: 26538149)
21. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
[TBL] [Abstract][Full Text] [Related]
22. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
Fowler SW; Chiang AC; Savjani RR; Larson ME; Sherman MA; Schuler DR; Cirrito JR; Lesné SE; Jankowsky JL
J Neurosci; 2014 Jun; 34(23):7871-85. PubMed ID: 24899710
[TBL] [Abstract][Full Text] [Related]
23. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice.
Leroy K; Ando K; Laporte V; Dedecker R; Suain V; Authelet M; Héraud C; Pierrot N; Yilmaz Z; Octave JN; Brion JP
Am J Pathol; 2012 Dec; 181(6):1928-40. PubMed ID: 23026200
[TBL] [Abstract][Full Text] [Related]
24. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
25. Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
Qiao J; Wang J; Wang H; Zhang Y; Zhu S; Adilijiang A; Guo H; Zhang R; Guo W; Luo G; Qiu Y; Xu H; Kong J; Huang Q; Li XM
Glia; 2016 Feb; 64(2):240-54. PubMed ID: 26446044
[TBL] [Abstract][Full Text] [Related]
26. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
27. Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models.
Qing H; He G; Ly PT; Fox CJ; Staufenbiel M; Cai F; Zhang Z; Wei S; Sun X; Chen CH; Zhou W; Wang K; Song W
J Exp Med; 2008 Nov; 205(12):2781-9. PubMed ID: 18955571
[TBL] [Abstract][Full Text] [Related]
28. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
29. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.
Jeong YJ; Kang GY; Kwon JH; Choi HD; Pack JK; Kim N; Lee YS; Lee HJ
Curr Alzheimer Res; 2015; 12(5):481-92. PubMed ID: 26017559
[TBL] [Abstract][Full Text] [Related]
30. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
[TBL] [Abstract][Full Text] [Related]
31. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
32. In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer's disease pathology.
Trujillo-Estrada L; Jimenez S; De Castro V; Torres M; Baglietto-Vargas D; Moreno-Gonzalez I; Navarro V; Sanchez-Varo R; Sanchez-Mejias E; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Acta Neuropathol Commun; 2013 Nov; 1():73. PubMed ID: 24252759
[TBL] [Abstract][Full Text] [Related]
33. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Naert G; Rivest S
J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
[TBL] [Abstract][Full Text] [Related]
35. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
36. The human-specific CASP4 gene product contributes to Alzheimer-related synaptic and behavioural deficits.
Kajiwara Y; McKenzie A; Dorr N; Gama Sosa MA; Elder G; Schmeidler J; Dickstein DL; Bozdagi O; Zhang B; Buxbaum JD
Hum Mol Genet; 2016 Oct; 25(19):4315-4327. PubMed ID: 27516385
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
[TBL] [Abstract][Full Text] [Related]
39. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease.
Kanninen K; Heikkinen R; Malm T; Rolova T; Kuhmonen S; Leinonen H; Ylä-Herttuala S; Tanila H; Levonen AL; Koistinaho M; Koistinaho J
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16505-10. PubMed ID: 19805328
[TBL] [Abstract][Full Text] [Related]
40. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
